Literature DB >> 12559149

Reality monitoring and visual hallucinations in Parkinson's disease.

J Barnes1, L Boubert, J Harris, A Lee, A S David.   

Abstract

Between 8 and 40% of Parkinson disease (PD) patients will have visual hallucinations (VHs) during the course of their illness. Although cognitive impairment has been identified as a risk factor for hallucinations, more specific neuropsychological deficits underlying such phenomena have not been established. Research in psychopathology has converged to suggest that hallucinations are associated with confusion between internal representations of events and real events (i.e. impaired-source monitoring). We evaluated three groups: 17 Parkinson's patients with visual hallucinations, 20 Parkinson's patients without hallucinations and 20 age-matched controls, using tests of visual imagery, visual perception and memory, including tests of source monitoring and recollective experience. The study revealed that Parkinson's patients with hallucinations appear to have intact visual imagery processes and spatial perception. However, there were impairments in object perception and recognition memory, and poor recollection of the encoding episode in comparison to both non-hallucinating Parkinson's patients and healthy controls. Errors were especially likely to occur when encoding and retrieval cues were in different modalities. The findings raise the possibility that visual hallucinations in Parkinson's patients could stem from a combination of faulty perceptual processing of environmental stimuli, and less detailed recollection of experience combined with intact image generation.

Entities:  

Mesh:

Year:  2003        PMID: 12559149     DOI: 10.1016/s0028-3932(02)00182-3

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  29 in total

1.  Quetiapine in the treatment of psychosis in Parkinson's disease.

Authors:  Paul Shotbolt; Mike Samuel; Anthony David
Journal:  Ther Adv Neurol Disord       Date:  2010-11       Impact factor: 6.570

2.  Brain correlates of subjective reality of physically and psychologically induced pain.

Authors:  Tuukka T Raij; Jussi Numminen; Sakari Närvänen; Jaana Hiltunen; Riitta Hari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 3.  Striatal contributions to declarative memory retrieval.

Authors:  Jason M Scimeca; David Badre
Journal:  Neuron       Date:  2012-08-09       Impact factor: 17.173

Review 4.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors:  C Mehler-Wex; P Riederer; M Gerlach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 5.  Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.

Authors:  Luigi Trojano; Costanza Papagno
Journal:  Neurol Sci       Date:  2017-10-16       Impact factor: 3.307

Review 6.  Psychosis in Parkinson's disease.

Authors:  B R Thanvi; T C N Lo; D P Harsh
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

Review 7.  Pathophysiology and treatment of psychosis in Parkinson's disease: a review.

Authors:  Laura B Zahodne; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

8.  Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.

Authors:  Matthew J Baggott; Jennifer D Siegrist; Gantt P Galloway; Lynn C Robertson; Jeremy R Coyle; John E Mendelson
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

Review 9.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

10.  Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease.

Authors:  Fiore Manganelli; Carmine Vitale; Gabriella Santangelo; Chiara Pisciotta; Rosa Iodice; Autilia Cozzolino; Raffaele Dubbioso; Marina Picillo; Paolo Barone; Lucio Santoro
Journal:  Brain       Date:  2009-07-07       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.